Development of an oral rutin nanocrystal formulation

被引:199
|
作者
Mauludin, Rachmat [1 ]
Mueller, Rainer H. [1 ]
Keck, Cornelia M. [1 ]
机构
[1] Free Univ Berlin, Dept Pharmaceut Biopharmaceut & NutriCosmet, D-12169 Berlin, Germany
关键词
Nanocrystals; Rutin; Lyophilization; Re-dispersion; Rutin nanocrystal-loaded tablet; Dissolution behavior; PARTICLE-SIZE REDUCTION; POORLY SOLUBLE DRUGS; DISSOLUTION RATE; BIOAVAILABILITY; NANOSUSPENSIONS; FLAVONOIDS; IMPROVEMENT; SOLUBILITY; ABSORPTION; QUERCETIN;
D O I
10.1016/j.ijpharm.2008.11.029
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dried rutin nanocrystals have been prepared by lyophilization and investigated regarding their physicochemical properties with respect to re-dispersability, particle size, morphology and dissolution behavior. Photon correlation spectroscopy (PCS) and laser diffractometry (LD) were employed to determine the particle size. Morphology of the particles was analyzed by light microscopy. Lyophilized rutin nanocrystals were incorporated into tablets and the dissolution behavior of the tablets was evaluated. Very fine particles of lyophilized rutin could be completely re-dispersed in the water. The PCS size average and polydispersity index (PI) of lyophilized rutin were of 721 nm and of 0.288 after re-dispersion. The rutin nanocrystal-loaded tablets were produced using direct compression. The dissolution velocity of the rutin nanocrystal-loaded tablet was superior compared to rutin microcrystal-loaded and a marketed tablet. After 30 min rutin was released and dissolved completely from the nanocrystal tablets in water. In contrast, only 71% and 55% of the total amount of rutin were dissolved from the microcrystal tablets and the marketed tablet, respectively. The improving dissolution behavior of the rutin nanocrystal-loaded tablet should lead to a better bioavailability of the poorly soluble rutin in the body. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:202 / 209
页数:8
相关论文
共 50 条
  • [1] Development of novel lutein nanocrystal formulation with improved oral bioavailability and ocular distribution
    Seto, Yoshiki
    Ueno, Kodai
    Suzuki, Hiroki
    Sato, Hideyuki
    Onoue, Satomi
    JOURNAL OF FUNCTIONAL FOODS, 2019, 61
  • [2] Bexarotene nanocrystal-Oral and parenteral formulation development, characterization and pharmacokinetic evaluation
    Chen, Lijiang
    Wang, Yongjie
    Zhang, Jiaozhen
    Hao, Leilei
    Guo, Hejian
    Lou, Hongxiang
    Zhang, Dianrui
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 87 (01) : 160 - 169
  • [3] Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation
    Chang, Daoxiao
    Ma, Yanni
    Cao, Guoyu
    Wang, Jianhuan
    Zhang, Xia
    Feng, Jun
    Wang, Wenping
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 (05) : 1018 - 1024
  • [4] Exploitation of nanocrystal suspension as an effective oral formulation for oxfendazole
    Sun, Yuzhu
    Chen, Dongmei
    Zhao, Ying
    Zhou, Kaixiang
    Zhang, Bao
    Wang, Haiting
    Xie, Shuyu
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2022, 12 (05) : 1219 - 1229
  • [5] Exploitation of nanocrystal suspension as an effective oral formulation for oxfendazole
    Yuzhu Sun
    Dongmei Chen
    Ying Zhao
    Kaixiang Zhou
    Bao Zhang
    Haiting Wang
    Shuyu Xie
    Drug Delivery and Translational Research, 2022, 12 : 1219 - 1229
  • [6] Enhanced oral bioavailability of glycyrrhetinic acid via nanocrystal formulation
    Yaya Lei
    Yindi Kong
    Hong Sui
    Jun Feng
    Rongyue Zhu
    Wenping Wang
    Drug Delivery and Translational Research, 2016, 6 : 519 - 525
  • [7] Enhanced oral bioavailability of glycyrrhetinic acid via nanocrystal formulation
    Lei, Yaya
    Kong, Yindi
    Sui, Hong
    Feng, Jun
    Zhu, Rongyue
    Wang, Wenping
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2016, 6 (05) : 519 - 525
  • [8] An Updated Review of Pharmacological, Standardization Methods and Formulation Development of Rutin
    Riaz, Humayun
    Raza, Syed Atif
    Aslam, Muhammad Shahzad
    Ahmad, Muhammad Syarhabil
    Ahmad, Mohammad Ayaz
    Maria, Povydysh
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2018, 12 (01): : 127 - 132
  • [9] DEVELOPMENT OF AN ORAL FORMULATION OF OMEPRAZOLE
    PILBRANT, A
    CEDERBERG, C
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1985, 20 : 113 - 120
  • [10] Development of nanocrystal formulation of mebendazole with improved dissolution and pharmacokinetic behaviors
    Naofumi Hashimoto
    Kayo Yuminoki
    Haruka Takeuchi
    Chiaki Okada
    AsianJournalofPharmaceuticalSciences, 2016, 11 (01) : 122 - 123